Zetacolest Plus Film Coated Tablet

INDICATIONS AND USAGE :
ZETACOLEST PLUS, a combination of bempedoic acid and ezetimibe, is indicated:
As an adjunct to diet, alone or in combination with other low-density lipoprotein
cholesterol (LDL-C) lowering therapies, to reduce LDL-C in adults with primary
hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH).
The bempedoic acid component of ZETACOLEST PLUS is indicated:
•To reduce the risk of myocardial infarction and coronary revascularization in adults
who are unable to take recommended statin therapy (including those not taking a
statin) with:-established cardiovascular disease (CVD), or-a high risk for a CVD event but without established CVD